HNI (NYSE:HNI) Lifted to Strong-Buy at StockNews.com

StockNews.com upgraded shares of HNI (NYSE:HNI – Free Report) from a buy rating to a strong-buy rating in a research note issued to investors on Saturday morning. Separately, Benchmark raised their target price on HNI from $57.00 to $63.00 and gave the company a buy rating in a research note on Friday, July 26th. Check […]

Leave a Reply

Your email address will not be published.

Previous post FibroGen (NASDAQ:FGEN) Research Coverage Started at StockNews.com
Next post StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)